The problem is that Pharma companies can't patent and sell a full spectrum product. They can only make the big bucks by getting a certain compound approved after going through the full FDA process on that one particular compound. It's the same thing we saw with kratom. The FDA had multiple attempts over the last 7 years to ban it, while kratom is basically as harmless as coffee. It took a massive grassroots effort to stop the ban. Then shortly after it comes out that GlaxoSmithKline, who the FDA head (Scott Gottlieb) at the time of the attempted ban sat on the board for just a year prior, was trying to bring synthetic 7-hydroxy-mitragynine (7hm is thought to be a main active ingredient in kratom) to market, which it has a patent on. Follow the money people